PHIP-associated Chung-Jansen syndrome: Report of 23 new individuals




Kampmeier Antje, Leitão Elsa, Parenti Ilaria, Beygo Jasmin, Depienne Christel, Bramswig Nuria C, Hsieh Tzung-Chien, Afenjar Alexandra, Beck-Wödl Stefanie, Grasshoff Ute, Haack Tobias B, Bijlsma Emilia K, Ruivenkamp Claudia, Lausberg Eva, Elbracht Miriam, Haanpää Maria K, Koillinen Hannele, Heinrich Uwe, Rost Imma, Jamra Rami Abou, Popp Denny, Koch-Hogrebe Margarete, Rostasy Kevin, López-González Vanessa, Sanchez-Soler Maria José, Macedo Catarina, Schmetz Ariane, Steinborn Carmen, Weidensee Sabine, Lesmann Hellen, Marbach Felix, Caro Pilar, Schaaf Christian P, Krawitz Peter, Wieczorek Dagmar, Kaiser Frank J, Kuechler Alma

PublisherFrontiers Research Foundation

2023

 Frontiers in cell and developmental biology

Frontiers in cell and developmental biology

Front Cell Dev Biol

1020609

10

2296-634X

DOIhttps://doi.org/10.3389/fcell.2022.1020609

https://www.frontiersin.org/articles/10.3389/fcell.2022.1020609/full

https://research.utu.fi/converis/portal/detail/Publication/178894346



In 2016 and 2018, Chung, Jansen and others described a new syndrome caused by haploinsufficiency of PHIP (pleckstrin homology domain interacting protein, OMIM *612,870) and mainly characterized by developmental delay (DD), learning difficulties/intellectual disability (ID), behavioral abnormalities, facial dysmorphism and obesity (CHUJANS, OMIM #617991). So far, PHIP alterations appear to be a rare cause of DD/ID. "Omics" technologies such as exome sequencing or array analyses have led to the identification of distinct types of alterations of PHIP, including, truncating variants, missense substitutions, splice variants and large deletions encompassing portions of the gene or the entire gene as well as adjacent genomic regions. We collected clinical and genetic data of 23 individuals with PHIP-associated Chung-Jansen syndrome (CHUJANS) from all over Europe. Follow-up investigations (e.g. Sanger sequencing, qPCR or Fluorescence-in-situ-Hybridization) and segregation analysis showed either de novo occurrence or inheritance from an also (mildly) affected parent. In accordance with previously described patients, almost all individuals reported here show developmental delay (22/23), learning disability or ID (22/23), behavioral abnormalities (20/23), weight problems (13/23) and characteristic craniofacial features (i.e. large ears/earlobes, prominent eyebrows, anteverted nares and long philtrum (23/23)). To further investigate the facial gestalt of individuals with CHUJANS, we performed facial analysis using the GestaltMatcher approach. By this, we could establish that PHIP patients are indistinguishable based on the type of PHIP alteration (e.g. missense, loss-of-function, splice site) but show a significant difference to the average face of healthy individuals as well as to individuals with Prader-Willi syndrome (PWS, OMIM #176270) or with a CUL4B-alteration (Intellectual developmental disorder, X-linked, syndromic, Cabezas type, OMIM #300354). Our findings expand the mutational and clinical spectrum of CHUJANS. We discuss the molecular and clinical features in comparison to the published individuals. The fact that some variants were inherited from a mildly affected parent further illustrates the variability of the associated phenotype and outlines the importance of a thorough clinical evaluation combined with genetic analyses for accurate diagnosis and counselling.


Last updated on 26/11/2024 02:00:17 PM